Popovtzer A., Popovtzer R., Agrawal A., Shlomi M., Popovtzer A., Popovtzer R., Balter J., Carey T.E., Kopelman R.
University of Michigan, US
Keywords: contrast agents, CT, molecular imaging, nanoparticles
This research describes a new class of immuno-targeted and cancer specific CT contrast agents, which enable CT imaging of cancer at cellular and molecular resolution. The method is based on the development of gold nano-probes that specifically and sensitively target in vivo tumor specific antigens, while inducing distinct contrast in CT imaging (increased x-ray attenuation). The overall goal of this research is to develop a novel cancer imaging tool, which may lead to improvements in therapy due to early detection, accurate staging and micro-tumor identification.
Journal: TechConnect Briefs
Volume: 2, Nanotechnology 2008: Life Sciences, Medicine & Bio Materials – Technical Proceedings of the 2008 NSTI Nanotechnology Conference and Trade Show, Volume 2
Published: June 1, 2008
Pages: 5 - 7
Industry sector: Medical & Biotech
Topics: Biomaterials, Cancer Nanotechnology
ISBN: 978-1-4200-8504-4